Release Date: 21/12/17 10:22 Summary: MSM Investor Briefing Price Sensitive: No Download Document 100.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago